Developing a transition-metal-free system for functionalizing the C(sp3)–H bond has posed a long-standing challenge in synthetic organic chemistry and is of significance in drug discovery. In this context, we present a straightforward protocol for the heteroarylation of benzylic and alpha-amino C–H bonds, achieved without transition metals or photocatalysts. A pivotal aspect of redox-neutral hydroarylation is the utilization of commercially available triisopropylsilanethiol (iPr3SiSH) as an organocatalyst. This organocatalyst serves a dual function in forming an electron donor–acceptor complex (EDA) and acting as a hydrogen atom transfer catalyst, generating alkyl/benzylic radicals from the corresponding C–H bonds. Applying this mild methodology, various benzylic and amino C–H bonds were functionalized to give a C(sp3)–H and C(sp2)–heteroaryl C–C cross-coupled product. To demonstrate the practical utility of this protocol, pyridine was incorporated into a drug molecule via late-stage modification. Additionally, a gram-scale reaction was also performed to show the advantages of this protocol.
No takes yet. Share an insight, caveat, or question.
Almagambetova et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: